Clinical trial

Study of Desvenlafaxine in Treating Major Depressive Disorder.

NCT04364997

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-06-18

PhasePHASE3

Study timeline

Study start (actual)2020-06-18Date precision: day

Registry last updated2021-12-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule PlaceboDRUG

Desvenlafaxine Succinate Sustained-Release Tablet Placebo, Duloxetine Hydrochloride Enteric-coated CapsuleDRUG

Duloxetine Hydrochloride Enteric-coated Capsule PlaceboDRUG

Duloxetine Hydrochloride Enteric-coated CapsuleDRUG

Sponsors & collaborators

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.lead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04364997 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.